As your trusted Single-Use Technologies (SUT) expert, SaniSureĀ® designs and manufactures components, fluid management systems, and custom assemblies for complex fluid paths and closed-system applications across bioprocessing and advanced therapiesāfrom upstream processing through final fill. With expertise in single-use system design, materials, and manufacturing, SaniSure works directly with customers to develop solutions tailored to their specific process requirements. Its open-architecture approach provides the flexibility to integrate components and technologies based on application needs rather than being limited to proprietary configurations. SaniSure combines in-house engineering, prototyping, component manufacturing, and assembly capabilities with a global manufacturing footprint. This vertical integration provides greater control over component sourcing, design, manufacturing, and quality. Through its broad component portfolio, custom engineering capabilities, and integrated manufacturing operations, SaniSure helps biomanufacturers address complex fluid management requirements, reduce supplier complexity, and support reliable manufacturing operations.
Looking for a particular SaniSure employee's phone or email?
The SaniSure annual revenue was $8.5 million in 2026.
Steven Chevillotte is the Chief Executive Officer (Biopharma, PE-backed) of SaniSure.
132 people are employed at SaniSure.
SaniSure is based in Camarillo, California.
The NAICS codes for SaniSure are [3254, 32541, 32, 325].
The SIC codes for SaniSure are [28, 283].